DE 13161/DE/NIDCR NIH HHS/United States[Grants and Funding] - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Year	Number of Results
2004	1
2005	1
2007	1
2025	0

Page 1

Combination treatment significantly enhances the efficacy of antitumor therapy by preferentially targeting angiogenesis.

Kumar P, Benedict R, Urzua F, Fischbach C, Mooney D, Polverini P. Kumar P, et al. Lab Invest. 2005 Jun;85(6):756-67. doi: 10.1038/labinvest.3700272. Lab Invest. 2005. PMID: 15864318 Free article.

Bcl-2 protects endothelial cells against gamma-radiation via a Raf-MEK-ERK-survivin signaling pathway that is independent of cytochrome c release.

Kumar P, Coltas IK, Kumar B, Chepeha DB, Bradford CR, Polverini PJ. Kumar P, et al. Cancer Res. 2007 Feb 1;67(3):1193-202. doi: 10.1158/0008-5472.CAN-06-2265. Cancer Res. 2007. PMID: 17283155

p38 MAPK mediates gamma-irradiation-induced endothelial cell apoptosis, and vascular endothelial growth factor protects endothelial cells through the phosphoinositide 3-kinase-Akt-Bcl-2 pathway.

Kumar P, Miller AI, Polverini PJ. Kumar P, et al. J Biol Chem. 2004 Oct 8;279(41):43352-60. doi: 10.1074/jbc.M405777200. Epub 2004 Aug 2. J Biol Chem. 2004. PMID: 15292252 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3 results

Results by year